Cargando…
C3 glomerulopathy and current dilemmas
C3 glomerulopathy (C3G) is a recently identified disease entity caused by dysregulation of the alternative complement pathway, and dense deposit disease (DDD) and C3 glomerulonephritis (C3GN) are its components. Because laboratory detection of complement dysregulation is still uncommon in practice,...
Autores principales: | Ito, Naoko, Ohashi, Ryuji, Nagata, Michio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721121/ https://www.ncbi.nlm.nih.gov/pubmed/27878657 http://dx.doi.org/10.1007/s10157-016-1358-5 |
Ejemplares similares
-
Current concepts in C3 glomerulopathy
por: Thomas, S., et al.
Publicado: (2014) -
C3 glomerulopathy
por: Cook, H. Terence
Publicado: (2017) -
Update on C3 glomerulopathy
por: Barbour, Thomas D., et al.
Publicado: (2016) -
Overview of C3 Glomerulopathy
por: Master Sankar Raj, Vimal, et al.
Publicado: (2016) -
Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies
por: Rudnicki, Michael
Publicado: (2017)